PPARalpha-independent actions of omega-3 PUFAs contribute to their beneficial effects on adiposity and glucose homeostasis
Excess dietary lipid generally leads to fat deposition and impaired glucose homeostasis, but consumption of fish oil (FO) alleviates many of these detrimental effects. The beneficial effects of FO are thought to be mediated largely via activation of the nuclear receptor peroxisomal-proliferator-activated receptor alpha (PPARalpha) by omega-3 polyunsaturated fatty acids and the resulting upregulation of lipid catabolism. However, pharmacological and genetic PPARalpha manipulations have yielded variable results. We have compared the metabolic effects of FO supplementation and the synthetic PPARalpha agonist Wy-14,643 (WY) in mice fed a lard-based high-fat diet. In contrast to FO, WY treatment resulted in little protection against diet-induced obesity and glucose intolerance, despite upregulating many lipid metabolic pathways. These differences were likely due to differential effects on hepatic lipid synthesis, with FO decreasing and WY amplifying hepatic lipid accumulation. Our results highlight that the beneficial metabolic effects of FO are likely mediated through multiple independent pathways.
|ISBN||2045-2322 (Electronic) 2045-2322 (Linking)|
|Authors||Liu, M.; Montgomery, M. K.; Fiveash, C. E.; Osborne, B.; Cooney, G. J.; Bell-Anderson, K.; Turner, N.;|
|Publisher Name||Scientific Reports|
|URL link to publisher's version||http://www.ncbi.nlm.nih.gov/pubmed/24986106|
|OpenAccess link to author's accepted manuscript version||https://publications.gimr.garvan.org.au/open-access/12374|